نتایج جستجو برای: neoadjuvant

تعداد نتایج: 15052  

2014
Susan Tsai Laura McOlash Douglas B Evans Bryon Johnson Jill Gershan

In most patients, pancreatic ductal adenocarcinoma (PDAC) is metastatic at diagnosis and available systemic therapies have had only a modest impact on survival duration. The overwhelming majority of patients with apparent localized, operable disease have extra-pancreatic micrometastases. Cancer patients experience both systemic and intra-tumor immune suppression. Thus, it is likely that pancrea...

Journal: :Gynecologic oncology 2005
Luca Fuso Simona Mazzola Francesco Marocco Annamaria Ferrero Daniela Dompè Alice Peroglio Carus Paolo Zola

OBJECTIVE The aim of this study was to evaluate the predictive value of pretreatment serum hemoglobin level (Hb) together with a series of clinical and pathological variables available before neoadjuvant chemotherapy in locally advanced squamous cervical cancer. METHODS The influence on response to neoadjuvant chemotherapy of a series of pretreatment clinico-pathological features: hemoglobin ...

Journal: :iranian journal of pathology 2008
mehdi seilanian toosi mohammad reza ghavam nasiri kamran ghafarzadegan azar fani pakdel roham salek

background and objective: p53 is a suppressive gene that plays a key role in dna repair and apoptosis. the purpose of this study was to investigate the effect of p53 protein over-expression and some clinicopathological factors on the esophageal squamous cell carcinoma (scc) response to neoadjuvant chemoradiotherapy. patients and methods: in this retrospective cohort study, 44 patients with loca...

2017
Jang Han Jung Hyun Jik Lee Hee Seung Lee Jung Hyun Jo In Rae Cho Moon Jae Chung Jeong Youp Park Seung Woo Park Si Young Song Seungmin Bang

AIM To clarify the role of neoadjuvant concurrent chemoradiotherapy (NACCRT) followed by surgical resection for localized or locally advanced perihilar cholangiocarcinoma (CCA). METHODS We retrospectively reviewed 57 patients who underwent surgical resection with or without NACCRT for perihilar CCA; 12 patients received NACCRT and 45 patients did not received NACCRT. Patients with locally adv...

2015
Sandra Heskamp Otto C. Boerman Janneke D. M. Molkenboer-Kuenen Carla A. Wauters Luc J. A. Strobbe Caroline M. P. W. Mandigers Peter Bult Wim J. G. Oyen Winette T. A. van der Graaf Hanneke W. M. van Laarhoven

INTRODUCTION The insulin-like growth factor 1 receptor (IGF-1R) may be involved in the development of resistance against conventional cancer treatment. The aim of this study was to assess whether IGF-1R expression of breast tumors changes during neoadjuvant therapy and to study whether these changes were associated with survival. METHODS Paraffin embedded tumor tissue was collected from pretr...

2018
Felix J. Hüttner Pascal Probst Eva Kalkum Matthes Hackbusch Katrin Jensen Alexis Ulrich Markus W. Büchler Markus K. Diener

BACKGROUND Neoadjuvant (chemo-)radiation has proven to improve local control compared to surgery alone, but this improvement did not translate into better overall or disease-specific survival. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemoradiotherapy holds the potential of positively affecting survival in this context since it has been proven effective in the palliativ...

2017
Li Yan Lim Hui Miao Joline S. J. Lim Soo Chin Lee Nirmala Bhoo‐Pathy Cheng Har Yip Nur Aishah B. M. Taib Patrick Chan Ern Yu Tan Swee Ho Lim Geok Hoon Lim Evan Woo Yia Swam Tan Jung Ah Lee Mabel Wong Puay Hoon Tan Kong Wee Ong Fuh Yong Wong Yoon Sim Yap Mikael Hartman

We aim to identify clinicopathologic predictors for response to neoadjuvant chemotherapy and to evaluate the prognostic value of pathologic complete response (pCR) on survival in Asia. This study included 915 breast cancer patients who underwent neoadjuvant chemotherapy at five public hospitals in Singapore and Malaysia. pCR following neoadjuvant chemotherapy was defined as 1) no residual invas...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Mei-Lin W Ah-See Andreas Makris N Jane Taylor Mark Harrison Paul I Richman Russell J Burcombe J James Stirling James A d'Arcy David J Collins Michael R Pittam Duraisamy Ravichandran Anwar R Padhani

PURPOSE Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) allows noninvasive, in vivo measurements of tissue microvessel perfusion and permeability. We examined whether DCE-MRI done after two cycles of neoadjuvant chemotherapy could predict final clinical and pathologic response in primary breast cancers. EXPERIMENTAL DESIGN Thirty-seven patients with primary breast cancer, due t...

2018
Ehab Hanafy Abdullah Al Jabri Gelan Gadelkarim Abdulaziz Dasaq Faisal Nazim Mohammed Al Pakrah

The management of oncological malignancies has significantly improved over the last decades. In modern medicine, new concepts and trends have emerged paving the way for the era of personalized and evidence-based strategies adapted to the patients' prognostic variables and requirements. Several challenges do exist that are encountered during the management, including the difficulty to assess che...

2015
Naoki Ozeki Koji Kawaguchi Takayuki Fukui, Koichi Fukumoto Shota Nakamura Toshiki Okasaka Kohei Yokoi

This study was designed to elucidate the predictive usefulness of the response evaluation criteria in solid tumors (RECIST), a volume response (VR; a > 50% reduction in the tumor volume) and the post-neoadjuvant therapy maximum standardized uptake value (post-SUVmax) in patients with non-small cell lung cancer (NSCLC) after neoadjuvant therapy. Between December 2006 and June 2012, 33 patients w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید